Welcome to our dedicated page for Restart Life news (Ticker: NMLSF), a resource for investors and traders seeking the latest updates and insights on Restart Life stock.
Restart Life Sciences Corp. reports developments in its better-for-you functional food and consumer packaged goods portfolio. The company operates through Holy Crap Foods Inc., a wholly owned subsidiary focused on superseed cereals, oatmeal and related gut-health products, and also references wellness product lines such as BrainQ™ and BrainBalls™ for cognitive health.
Recurring updates cover Holy Crap Foods integration, wholesale and e-commerce sales channels, Amazon Canada and Walmart.ca distribution, certified manufacturing capabilities, product development with the University of Manitoba’s Richardson Centre for Food Technology and Research, and internal infrastructure for brand scaling. Company news also includes board appointments, capital-markets oversight, related-party share issuance disclosures and broader operational execution across its functional wellness platform.
Nova Mentis Life Science Corp. has partnered with Mycrodose Therapeutics to develop patented products targeting neuroinflammatory disorders, including fragile X syndrome and autism spectrum disorder. This collaboration aims to leverage Mycrodose's advanced drug delivery systems and NOVA's psilocybin therapeutic, which has shown promising preclinical results. The partnership could broaden the patient base for psilocybin treatments, especially in pediatric applications. NOVA has applied for Orphan Drug designation, providing significant financial and regulatory benefits.